10 studies found for:
Open Studies | "Jejunal Diseases"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
|
||||
| 2 | Unknown † |
Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
|
||||
| 3 | Recruiting |
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
|
||||
| 4 | Unknown † |
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
|
||||
| 5 | Recruiting |
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
|
||||
| 6 | Recruiting |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
||||
| 7 | Recruiting |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
|
||||
| 8 | Unknown † |
Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
|
||||
| 9 | Recruiting |
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
|
||||
| 10 | Unknown † |
Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia
|
† Indicates status has not been verified in more than two years